Franklin Resources Inc Halozyme Therapeutics, Inc. Transaction History

Franklin Resources Inc

$334 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 837,739 shares of HALO stock, worth $39.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

837,739

Previous 837,739 -0.0%

Holding current value

$39.8 Million

Previous $47.9 Million -0.0%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$51.3 - $64.42 $19.1 Million - $24 Million	372,066 Added 79.9%	837,739 $47.9 Million
Q2 2024 Aug 14, 2024	BUY	$37.81 - $52.4 $5.97 Million - $8.28 Million	157,969 Added 51.34%	465,673 $24.4 Million
Q1 2024 May 13, 2024	BUY	$33.68 - $41.95 $7.88 Million - $9.81 Million	233,909 Added 316.97%	307,704 $12.5 Million
Q4 2023 Feb 09, 2024	BUY	$33.32 - $42.1 $1,965 - $2,483	59 Added 0.08%	73,795 $2.73 Million
Q3 2023 Nov 13, 2023	SELL	$36.46 - $44.03 $122,542 - $147,984	-3,361 Reduced 4.36%	73,736 $2.82 Million
Q2 2023 Aug 11, 2023	SELL	$30.28 - $38.74 $13.9 Million - $17.8 Million	-458,942 Reduced 85.62%	77,097 $2.78 Million
Q1 2023 May 12, 2023	SELL	$32.86 - $55.7 $17.4 Million - $29.4 Million	-528,424 Reduced 49.64%	536,039 $20.5 Million
Q4 2022 Feb 10, 2023	SELL	$40.06 - $59.44 $66,860 - $99,205	-1,669 Reduced 0.16%	1,064,463 $60.6 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $14.6 Million - $19.6 Million	377,916 Added 54.91%	1,066,132 $42.2 Million
Q2 2022 Aug 11, 2022	BUY	$37.35 - $48.3 $24.1 Million - $31.2 Million	646,475 Added 1548.78%	688,216 $30.3 Million
Q1 2022 May 13, 2022	SELL	$31.97 - $41.06 $70,046 - $89,962	-2,191 Reduced 4.99%	41,741 $1.66 Million
Q4 2021 Feb 11, 2022	BUY	$31.82 - $40.75 $104,592 - $133,945	3,287 Added 8.09%	43,932 $1.77 Million
Q3 2021 Nov 12, 2021	BUY	$38.47 - $46.42 $1.29 Million - $1.56 Million	33,510 Added 469.66%	40,645 $1.65 Million
Q2 2021 Aug 13, 2021	BUY	$38.84 - $51.31 $19,225 - $25,398	495 Added 7.45%	7,135 $324,000
Q1 2021 May 13, 2021	BUY	$39.51 - $51.45 $18,648 - $24,284	472 Added 7.65%	6,640 $277,000
Q4 2020 Feb 10, 2021	BUY	$25.81 - $43.62 $159,196 - $269,048	6,168 New	6,168 $263,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Halozyme Therapeutics, Inc. Transaction History